Development of a rapid and sensitive recombinase polymerase amplification-lateral flow assay for detection of Burkholderia mallei.


Journal

Transboundary and emerging diseases
ISSN: 1865-1682
Titre abrégé: Transbound Emerg Dis
Pays: Germany
ID NLM: 101319538

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 22 10 2018
revised: 31 12 2018
accepted: 03 01 2019
pubmed: 17 1 2019
medline: 7 5 2019
entrez: 17 1 2019
Statut: ppublish

Résumé

Burkholderia mallei, a potential biothreat agent is the aetiological agent of glanders, a zoonotic disease primarily affecting equines. B. mallei shares close genetic proximity with B. pseudomallei, the aetiological agent of melioidosis. Hence, molecular detection of B. mallei and its differentiation from B. pseudomallei has always been challenging. Early diagnosis of glanders is critical for timely treatment in humans and disease containment in animals. In this study a recombinase polymerase amplification-lateral flow (RPA-LF) assay has been developed for early and accurate detection of B. mallei. RPA-LF assay was found to be highly sensitive and detected as low as 10 fg genomic DNA of B. mallei. The assay was highly specific and could differentiate B. mallei and B. pseudomallei. The assay also detected B. mallei in artificially spiked blood, tap water and garden soil. The established assay is simple, rapid and does not require complex instrumentation. The field deployable assay can have better implications in rapid glanders diagnosis and environmental detection of B. mallei over PCR-based detection tools in glanders endemic areas with limited laboratory resources.

Identifiants

pubmed: 30650261
doi: 10.1111/tbed.13126
doi:

Substances chimiques

DNA, Bacterial 0
Recombinases 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1016-1022

Subventions

Organisme : DRDO

Informations de copyright

© 2019 Blackwell Verlag GmbH.

Auteurs

Apoorva Saxena (A)

Bioprocess Technology Division, Defence Research and Development Establishment, Gwalior, India.

Vijai Pal (V)

Bioprocess Technology Division, Defence Research and Development Establishment, Gwalior, India.

Nagesh Kumar Tripathi (NK)

Bioprocess Technology Division, Defence Research and Development Establishment, Gwalior, India.

Ajay Kumar Goel (AK)

Bioprocess Technology Division, Defence Research and Development Establishment, Gwalior, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH